Association between dyslipidemia and depression: a cross-sectional analysis of NHANES data from 2007 to 2018 Authors: Xuemin Zhong, Jinxuan Ming, Changqing Li Published: 2024 ABSTRACT BackgroundThe relationship between depression and dyslipidemia remains controversial, with inconsistent findings across studies. This study aimed to investigate the association between blood lipid levels and depression using data from the National Health and Nutrition Examination Survey (NHANES) spanning from 2007 to 2018.MethodsThis cross-sectional study included 12,819 adult participants from NHANES. Depression was assessed using a nine-item depression screening instrument. Serum lipid levels, including total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG), were measured using Roche modular P and Roche Cobas 6000 chemistry analyzers. Survey-weighted multiple logistic regression was used to assess the relationships between serum lipid levels and depression.ResultsWe observed a statistically significant negative association between HDL levels and depression (odds ratio [OR]: 0.72, 95% confidence interval [CI]: 0.58–0.90). After adjustments for covariates, HDL-C, TG, and the triglyceride glucose (TyG) index showed significant associations with depression (ORs: 0.66, 1.08, and 1.01, respectively). A linear correlation was observed between HDL-C levels and depression (P < 0.01), while TG levels and the TyG index exhibited nonlinear associations (p < 0.01 and p < 0.05, respectively). No significant positive associations were observed between increased TC or LDL-C levels and the risk of depression.ConclusionsHigh HDL-C levels were negatively associated with depression, while TG levels and the TyG index were positively associated with depression. Clinical attention should be given to the detection of lipid levels in patients with depression.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12888-024-06359-x. Background Depression is a major public health challenge, affecting an estimated 320 million people worldwide and is projected to become the leading global disease burden by 2030 [1, 2]. Despite extensive research into its pathophysiology over many years, the precise mechanisms underlying depression remain unclear [3]. In recent years, it was suggested that the occurrence of depression is closely related to dyslipidemia [4]. Depression and dyslipidemia share a common pathological mechanism. However, existing studies have primarily focused on examining the relationship between depression and dyslipidemia, yielding mixed results that underscore the complexity of the possible associations between depression and lipid biomarkers [5]. These discrepancies may be attributed to variations in study designs and methodologies, including restricted age ranges, small sample sizes, and heterogeneous populations [6, 7]. Therefore, this study aimed to explore the associations between blood lipid levels and depression using data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2018. Our findings will shed light on the intricate relationship between depression and dyslipidemia, offering valuable insights for clinicians in developing more targeted interventions and management strategies for individuals with depressive disorders. Methods Study population from NHANES This cross-sectional study included 12,819 adult participants from NHANES (accessed on February 15, 2024) (https://www.cdc.gov/nchs/nhanes/index.htm). The patient selection process is illustrated in Fig. 1. Exclusion criteria comprised the following: (1) participants lacking data on depression outcomes; (2) participants with missing values for total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and fasting blood glucose; and (3) participants with a history of congestive heart failure, coronary heart disease, angina, angina pectoris, heart attack, or stroke (lipid levels are often used to assess cardiovascular risk; therefore, participants who self-reported having cardiovascular disease were excluded from this study). The NCHS Research Ethics Review Board approved the study protocol, and all participants provided written informed consent. Fig. 1Flow chart of the screening process for the selection of eligible participants Flow chart of the screening process for the selection of eligible participants Assessing covariates Data were obtained on sociodemographic factors, including age at the time of screening, sex, race, marital status, and education level; body mass index (BMI); lifestyle factors, including smoking status, physical activity level, and alcohol consumption; and lipid levels. Race was classified into five groups: Mexican American, Non-Hispanic White, Non-Hispanic Black, Other Hispanic, and Other. Education level was aggregated into four groups: (1) some college or AAA degree; (2) college graduate or above; (3) high school graduate/GED or equivalent; and (4) less than high school. BMI was calculated as weight in kilograms divided by the square of height in meters (kg/m2) and was classified into three groups: under/normal weight (BMI < 25 kg/m2), overweight (25 ≤ BMI < 30 kg/m2), and obese (BMI ≥ 30 kg/m2). Smoking was defined as follows: never smoked (participants who smoked fewer than 100 cigarettes in their lifetime) and smoking (participants who smoked more than 100 cigarettes in their lifetime). Physical activity was categorized as yes or no. Drinking (alcohol consumption) was defined as follows: never drinking (less than 12 drinks per year) or drinking (at least 12 drinks per year). Lipid data included TC, HDL-C, LDL-C, and TG levels, measured using Roche Modular P and Roche Cobas 6000 chemistry analyzers [8]. The LDL-C level was calculated using the Friedewald equation: LDL-C = (TC) – (HDL-C) – (TG/5). The triglyceride glucose (TyG) index was calculated using the formula: TyG = ln [TG (mg/dL) × glucose (mg/dL)/2]. Fasting blood glucose levels were measured at baseline when the participants provided blood samples. Assessment of outcome: major depression The primary outcome was depressive.Depression was assessed using a nine-item depression screening instrument (DPQ). Only data from participants aged 18 and older were included. For each symptom question, points ranging from 0 to 3 are associated with the response categories “not at all,” “several days,” “more than half the days,” and “nearly every day.” This screening instrument incorporates the DSM-IV depression diagnostic criteria. For this study, we defined MDD as a DPQ score of ≥ 10 [9–11]. Statistical analysis As NHANES is a survey aimed at representing the entire nation, it employs a sophisticated sampling method that involves stratification, multiple stages, and a probability-cluster design. We incorporated a complex sample design using sampling weights in our analysis to ensure an accurate representation of the American population. Consistent with NHANES guidelines, combined sampling weights were applied for data interpretation [12, 13]. We used a multiple interpolation method to address the missing values. Categorical variables are presented as percentages, whereas continuous variables are presented as medians [P25, P75]. Survey-weighted multiple logistic regression was used to assess the relationships between serum lipid levels (TC, HDL-C, LDL-C, TG, and TyG) and depression. Model 1 was adjusted for demographic factors (sex, race, education level, and marital status), and Model 2 was adjusted for Model 1 variables plus BMI and smoking status. The results are expressed as odds ratios (ORs) and 95% confidence intervals (CIs) in the logistic regression models. The relationship between serum lipid levels and depression was examined within subgroups defined by sex, BMI, and smoking status. Furthermore, restricted triple spline analyses adjusted for the same variables as in Model 2 were performed to account for the dose–response relationship (linear or nonlinear) between HDL-C, TG, and TyG levels and depression. Nonlinearity tests were performed using likelihood-ratio tests. All statistical analyses were performed using R software (version 4.1.3) with sampling weights, with p-values < 0.05 indicating statistical significance. Results Basic characteristics of the weighted sample The NHANES sample from 2007 to 2018 comprised 59,842 adult participants. After excluding patients with cardiovascular disease and those with missing DPQ and covariates, 12,819 participants remained. Among these participants, 980 (7.64%) had depression, while 11,839 (92.36%) did not when unweighted. The weighted percentages for depression and non-depression were 6.74% and 93.26%, respectively. The demographic characteristics, weighted according to the sample, are provided in Table 1. The mean age of the participants was 46 years, and no significant differences were observed in terms of age and alcohol use between participants with and without depression; however, statistically significant differences were found for sex, race, educational level, marital status, smoking status, and BMI. Table 1Weighted baseline characteristics of patients with or without depressionVariableTotalWithout depressionWith depressionp-valueAge46.00 [31.00, 61.00]44.00 [30.00, 58.00]44.00 [31.52, 56.00]0.70BMI, % Under/normal weight (< 25.0 km/m2)30.5231.0028.10< 0.01 Overweight (25.0–29.9 km/m2)33.5034.2024.90 Obese (≥ 30.0 km/m2)35.9834.9047.00Sex, % Female51.3050.3063.90< 0.01 Male48.7049.7036.10Race, % Mexican American16.449.307.60< 0.01 Non-Hispanic Black20.0610.8013.80 Non-Hispanic White40.4466.4063.00 Other Hispanic11.045.908.40 Other12.027.707.20Marital status, % Married/Living with a partner59.0564.0046.50< 0.01 Never married20.9220.3023.40 Divorced/Separated/Windowed20.3015.6030.10Education, % Some college or AAA degree30.1931.5035.80< 0.01 College graduate or above24.3931.8014.80 High school grad/GED or equivalent23.0622.7026.40 Less than high school22.3614.0023.10Total cholesterol (mmol/L)4.86 [4.22,5.59]4.86 [4.24, 5.59]4.97 [4.24, 5.74]0.240High-density lipoprotein cholesterol (mmol/L)1.34 [1.11,1.63]1.34 [1.11, 1.63]1.29 [1.06, 1.58]< 0.01Low-density lipoprotein cholesterol (mmol/L)2.90 [2.30,3.50]2.90 [2.30, 3.50]2.90 [2.40, 3.60]0.271Triglycerides (mmol/L)1.12 [0.79,1.65]1.09 [0.76, 1.61]1.25 [0.82, 1.87]< 0.01TyG3.18 [2.07,4.97]3.07 [2.03, 4.72]3.64 [2.25, 5.67]< 0.01BMI, body mass index; TyG, triglyceride-glucose Table 1Weighted baseline characteristics of patients with or without depressionVariableTotalWithout depressionWith depressionp-valueAge46.00 [31.00, 61.00]44.00 [30.00, 58.00]44.00 [31.52, 56.00]0.70BMI, % Under/normal weight (< 25.0 km/m2)30.5231.0028.10< 0.01 Overweight (25.0–29.9 km/m2)33.5034.2024.90 Obese (≥ 30.0 km/m2)35.9834.9047.00Sex, % Female51.3050.3063.90< 0.01 Male48.7049.7036.10Race, % Mexican American16.449.307.60< 0.01 Non-Hispanic Black20.0610.8013.80 Non-Hispanic White40.4466.4063.00 Other Hispanic11.045.908.40 Other12.027.707.20Marital status, % Married/Living with a partner59.0564.0046.50< 0.01 Never married20.9220.3023.40 Divorced/Separated/Windowed20.3015.6030.10Education, % Some college or AAA degree30.1931.5035.80< 0.01 College graduate or above24.3931.8014.80 High school grad/GED or equivalent23.0622.7026.40 Less than high school22.3614.0023.10Total cholesterol (mmol/L)4.86 [4.22,5.59]4.86 [4.24, 5.59]4.97 [4.24, 5.74]0.240High-density lipoprotein cholesterol (mmol/L)1.34 [1.11,1.63]1.34 [1.11, 1.63]1.29 [1.06, 1.58]< 0.01Low-density lipoprotein cholesterol (mmol/L)2.90 [2.30,3.50]2.90 [2.30, 3.50]2.90 [2.40, 3.60]0.271Triglycerides (mmol/L)1.12 [0.79,1.65]1.09 [0.76, 1.61]1.25 [0.82, 1.87]< 0.01TyG3.18 [2.07,4.97]3.07 [2.03, 4.72]3.64 [2.25, 5.67]< 0.01BMI, body mass index; TyG, triglyceride-glucose Weighted baseline characteristics of patients with or without depression BMI, body mass index; TyG, triglyceride-glucose Association between serum lipid levels and depression The association between serum lipid levels and depression is shown in Table 2. Elevated levels of TG and the TyG index were associated with an increased risk of depression. The results of the unadjusted model, Model 1, and Model 2 were consistent. The unadjusted model only accounted for HDL-C and revealed a statistically significant negative association between HDL-C levels and depression, with an OR of 0.72 (95% CI: 0.58–0.90). Model 2, adjusted for sex, race, education level, marital status, BMI, and smoking status, demonstrated ORs of 0.66 (95% CI: 0.50–0.87), 1.08 (95% CI: 1.01–1.15), and 1.01 (95% CI: 1.00–1.02) for HDL-C, TG, and TyG levels, respectively. No significant positive association was observed between TC and LDL-C levels and the risk of depression (p > 0.05). Table 2Association between serum lipid levels and depressionSerum LipidUnadjusted modelModel 1Model 2OR (95% CI)p-valueOR (95% CI)p-valueOR (95% CI)p-valueTotal cholesterol1.07 (0.98, 1.17)0.1401.05 (0.96,1,15)0.3001.04 (0.94, 1.14)0.500Low-density lipoprotein cholesterol1.06 (0.95, 1.19)0.3001.05 (0.94, 1.18)0.3001.04 (0.93, 1.17)0.500High-density lipoprotein cholesterol0.72 (0.58,0.90)0.0030.59 (0.45,0.76)< 0.0010.66 (0.50, 0.87)0.003Triglycerides1.09 (1.04, 1.15)0.0011.10 (1.03, 1.18)0.0051.08 (1.01, 1.15)0.021TyG1.02 (1.01, 1.03)< 0.0011.02 (1.00, 1.03)0.0041.01 (1.00, 1.02)0.019Note: Model 1 was adjusted for sex, race, education level, and marital status; Model 2 was further adjusted for smoking status and body mass index, based on Model 1. OR, odds ratio; CI, confidence interval; TyG, triglyceride-glucose Table 2Association between serum lipid levels and depressionSerum LipidUnadjusted modelModel 1Model 2OR (95% CI)p-valueOR (95% CI)p-valueOR (95% CI)p-valueTotal cholesterol1.07 (0.98, 1.17)0.1401.05 (0.96,1,15)0.3001.04 (0.94, 1.14)0.500Low-density lipoprotein cholesterol1.06 (0.95, 1.19)0.3001.05 (0.94, 1.18)0.3001.04 (0.93, 1.17)0.500High-density lipoprotein cholesterol0.72 (0.58,0.90)0.0030.59 (0.45,0.76)< 0.0010.66 (0.50, 0.87)0.003Triglycerides1.09 (1.04, 1.15)0.0011.10 (1.03, 1.18)0.0051.08 (1.01, 1.15)0.021TyG1.02 (1.01, 1.03)< 0.0011.02 (1.00, 1.03)0.0041.01 (1.00, 1.02)0.019Note: Model 1 was adjusted for sex, race, education level, and marital status; Model 2 was further adjusted for smoking status and body mass index, based on Model 1. OR, odds ratio; CI, confidence interval; TyG, triglyceride-glucose Association between serum lipid levels and depression Note: Model 1 was adjusted for sex, race, education level, and marital status; Model 2 was further adjusted for smoking status and body mass index, based on Model 1. OR, odds ratio; CI, confidence interval; TyG, triglyceride-glucose Restricted cubic splines analysis investigating the relationship between HDL-C, TG, and TyG levels and depression As shown in Fig. 2, we utilized restricted cubic splines (RCS) to flexibly model and visualize the associations between HDL-C, TG, and TyG levels and depression. After adjusting for covariates in Model 2 (as described above), a linear correlation was observed between HDL-C levels and depression (P-overall < 0.001, P-nonlinear = 0.547). TG levels and the TyG index exhibited nonlinear associations with depression (P-overall < 0.001 and P-nonlinear < 0.05, respectively). Fig. 2The exposure–response curve of high-density cholesterol, triglyceride, triglyceride glucose index, and depression The exposure–response curve of high-density cholesterol, triglyceride, triglyceride glucose index, and depression Subgroup Analysis Table 3 presents the results of the subgroup analyses. TG levels (OR: 1.10, 95% CI: 1.04–1.17) and the TyG index (OR: 1.02, 95% CI: 1.01–1.03) were positively associated with depression among male participants. HDL-C was more protective against depression among female participants (OR: 0.70, 95% CI: 0.50–1.00), and its level was negatively associated with depression among obese participants (OR: 0.61, 95% CI: 0.41–0.92). In participants who were under/normal weight, obese, or non-smokers, TG levels and the TyG index were not significantly associated with depression, whereas they were positively associated with the risk of depression among smokers (OR: 1.12, 95% CI: 1.05–1.20, P = 0.001 and OR: 1.02, 95% CI: 1.01–1.04, P = 0.001, respectively). Table 3Subgroup analyses stratified by sex, marital status, education level, and BMIHDLTriglyceridesTyGOR (95% CI)p-valueOR (95% CI)p-valueOR (95% CI)p-valueSex Female0.70 (0.50, 1.00)0.0431.05 (0.96, 1.15)0.31.01 (0.99, 1.03)0.2 Male0.60 (0.36,1.00)0.0451.10 (1.04, 1.17)< 0.0011.02 (1.01, 1.03)0.003BMI Under/normal weight0.72 (0.44, 1.18)0.21.08 (0.84, 1.39)0.61.01 (0.95, 1.08)0.7 Overweight0.65 (0.39, 1.09)0.11.14 (1.05,1.23)0.0021.02 (1.00, 1.03)0.015 Obese0.61 (0.41, 0.92)0.0161.05 (0.98, 1.12)0.21.01 (1.00, 1.02)0.1Smoking < 100 cigarettes in life0.81 (0.56, 1.17)0.31.03 (0.98, 1.10)0.21.00 (0.99, 1.01)0.5 ≥ 100 cigarettes in life0.56 (0.37, 0.87)0.0081.12 (1.05, 1.20)0.0011.02 (1.01, 1.04)0.001Note: Adjusted for sex, race, marital status, education level, BMI, and smoking status, except for the stratification factor. BMI*: BMI was classified as under/normal weight (BMI < 25 kg/m2), overweight (25 ≤ BMI < 30 kg/m2), and obese (BMI ≥ 30 kg/m2). OR, odds ratio; CI, confidence interval; BMI, body mass index; TyG, triglyceride-glucose Table 3Subgroup analyses stratified by sex, marital status, education level, and BMIHDLTriglyceridesTyGOR (95% CI)p-valueOR (95% CI)p-valueOR (95% CI)p-valueSex Female0.70 (0.50, 1.00)0.0431.05 (0.96, 1.15)0.31.01 (0.99, 1.03)0.2 Male0.60 (0.36,1.00)0.0451.10 (1.04, 1.17)< 0.0011.02 (1.01, 1.03)0.003BMI Under/normal weight0.72 (0.44, 1.18)0.21.08 (0.84, 1.39)0.61.01 (0.95, 1.08)0.7 Overweight0.65 (0.39, 1.09)0.11.14 (1.05,1.23)0.0021.02 (1.00, 1.03)0.015 Obese0.61 (0.41, 0.92)0.0161.05 (0.98, 1.12)0.21.01 (1.00, 1.02)0.1Smoking < 100 cigarettes in life0.81 (0.56, 1.17)0.31.03 (0.98, 1.10)0.21.00 (0.99, 1.01)0.5 ≥ 100 cigarettes in life0.56 (0.37, 0.87)0.0081.12 (1.05, 1.20)0.0011.02 (1.01, 1.04)0.001Note: Adjusted for sex, race, marital status, education level, BMI, and smoking status, except for the stratification factor. BMI*: BMI was classified as under/normal weight (BMI < 25 kg/m2), overweight (25 ≤ BMI < 30 kg/m2), and obese (BMI ≥ 30 kg/m2). OR, odds ratio; CI, confidence interval; BMI, body mass index; TyG, triglyceride-glucose Subgroup analyses stratified by sex, marital status, education level, and BMI Note: Adjusted for sex, race, marital status, education level, BMI, and smoking status, except for the stratification factor. BMI*: BMI was classified as under/normal weight (BMI < 25 kg/m2), overweight (25 ≤ BMI < 30 kg/m2), and obese (BMI ≥ 30 kg/m2). OR, odds ratio; CI, confidence interval; BMI, body mass index; TyG, triglyceride-glucose Discussion This cross-sectional analysis of NHANES data from to 2007 to 2018 revealed several significant associations with depression. High BMI and female sex were associated with depression. HDL-C levels were negatively associated with depression, while TG levels and the TyG index were positively associated with depression. However, TC and LDL-C levels were not associated with depression. The RCS curve was consistent with the results of multivariate analysis. Some previous studies have reported sex-specific correlations between lipid levels and depression, with lower HDL-C and LDL-C concentrations being associated with a higher depression prevalence primarily in women and men, respectively [14, 15]. In contrast, our study found a higher prevalence of depression among female participants in the absence of sex-based differences in the relationship between depression and dyslipidemia. This lack of sex disparity might be attributed to the large sample size and comprehensive data included in our study, mitigating potential errors resulting from population heterogeneity. Furthermore, our findings revealed an association between a high BMI and depression, consistent with existing evidence indicating a higher risk of depression among individuals with a higher BMI, particularly in populations of European descent [16]. However, understanding how the relationship between different environments and ancestral backgrounds influences these associations remains limited. Researchers from Karolinska University in Sweden recently explored the relationship between body composition and depression in individuals of East Asian ancestry. Their study revealed an inverse relationship between BMI and depression in this population, contrasting with previous findings in European populations [17]. The association between depression and TC and LDL-C levels remains controversial [18–20]. Some studies reported slightly higher TC and LDL-C levels in individuals with depression [21, 22], while others have failed to show a correlation [23]. Previous studies have suggested that excess TC and LDL-C can directly bind to various serotonin receptors or transporters, or indirectly change the fluidity and structure of neuronal cell membrane, thereby decreasing serotonin receptor sensitivity or serotonin transporter activity in patients [24, 25]. Meanwhile, other studies have speculated that the pathogenesis of depression may be different at different ages [26, 27]. The current study found no association between TC or LDL-C levels and depression. Given the high prevalence of dyslipidemia in patients with cardiovascular and cerebrovascular diseases, and considering that long-term use of statins as lipid-lowering drugs in such patients may influence the results, we excluded patients with cardiovascular and cerebrovascular diseases from our analysis. Therefore, our study’s negative results may be attributed to this exclusion criterion. Previous studies have examined the association between HDL-C levels and depression. A meta-analysis of 29 cross-sectional studies found an association between depressive symptoms and reduced HDL-C levels [28]. In a national study in South Korea, a negative association was identified between HDL-C levels and depression [29]. Similarly, another study confirmed the association between depression and HDL-C levels by examining the neural connection between depression and changes in HDL-C levels [30]. Consistent with these prior findings, our study also observed an inverse association between HDL-C levels and depression. Evidence suggests that depression is an inflammatory disease, and peripheral immune activation leads to behavioral, neurobiochemical, and neuroendocrine changes associated with depression through the release of proinflammatory cytokines [31–33]. HDL-C induces anti-inflammatory effects, and reducing the concentration of HDL-C can trigger a significant inflammatory response, thereby reducing the risk of depression [34–37]. However, some previous studies have found that HLD-C has different effects on patients with depression of different ages [38, 39]. Given that no firm conclusions have been established on the association between depression and HLD-C levels at different ages, further discussion is needed in the future. Consistent with previous findings, we observed a positive correlation between TG levels and depression [40, 41]. Furthermore, a Mendelian randomized analysis of lipid levels and depression phenotypes suggested a causal relationship between TG levels and depression [42]. In addition, the present study found an association between depression and the TyG index—a newly discovered index of insulin resistance (IR). Previous observational studies have indicated that as IR increases, the risk of depression also increases by 4% in young people and by 17% in individuals without diabetes [43]. A cross-sectional study reported that an elevated TyG index is associated with a higher risk of depression among the general population [44]. Furthermore, research conducted in The Netherlands found that patients with MDD were more likely to develop IR, with a 51% increased risk compared with patients without depressive disorders. Similarly, IR has been associated with the severity of depression [35]. Current research on IR as a co-pathogenesis of depression and type 2 diabetes highlights the potential role of reduced insulin signaling in the brain due to metabolic imbalances in the behavioral mechanisms of depression [45, 46]. Limitations Based on the NHANES database, epidemiological survey data were obtained to facilitate the analyses and control for various confounding factors, thereby obtaining more accurate research results. However, this investigation was solely a correlation study between depressive symptoms and blood lipid biomarkers, making it impossible to determine whether a causal relationship exists between the two owing to the inherent limitations of cross-sectional studies. Secondly, we employed the PHQ-9 questionnaire to identify depression. Despite its established reliability as a definition criterion, potential bias might have arose from vague definitions. Finally, although we made extensive adjustments to account for potential confounding factors, it is possible that some unmeasured or residual confounding effects were not fully accounted for. Conclusion Lipid levels are closely associated with the occurrence and development of depression. This study identified a negative correlation between HDL-C levels and depression, as well as positive correlations between TG levels and the TyG index and depression. Hence, clinical attention should be directed towards monitoring lipid levels in patients with depression. HDL-C, TG, and the TyG index could serve as biological markers of depression, and are potential intervention targets for depression treatment and prevention. However, further research on the biological and behavioral mechanisms of these biomarkers is needed. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1